Edrophonium

Back to search

Molecule Structure

Scientific Name

Edrophonium

Description of the Drug

Edrophonium is a cholinesterase inhibitor used to diagnose and evaluate myasthenia gravis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01010

Brand Name(s)

Not Available

Company Owner(s)

Watson Laboratories Inc, Teligent Pharma Inc, Organon Usa Inc, Mylan Institutional Llc, Hospira Worldwide, Inc, Mylan Institutional Llc A Viatris Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Acetylcholinesterase SINGLE PROTEIN INHIBITOR CHEMBL220

Unichem Links

SureChEMBL SCHEMBL34790
PharmGKB PA449437
Human Metabolome Database HMDB0015145
WDI EDROPHONU
DrugBank DB01010
PubChem 3202
Mcule MCULE-5963849469
LINCS LSM-5867
Nikkaji J5.502F
PDBe EDR
BindingDB 120262
EPA CompTox Dashboard DTXSID4046943
DrugCentral 988
Brenda 5271
Guide to Pharmacology 9073
GSRS 492b283f-90e9-4c21-a6a4-9b62ac1740f5
rxnorm EDROPHONIUM EDROPHONIUM CHLORIDE ENLON-PLUS ENLON EDROPHONIUM CATION
KEGG Ligand C06976
ChEBI 251408
ZINC ZINC000000001341